RSV Vaccines See Historic Uptake as Market Set to Exceed US$ 15.9 Billion
The global Respiratory Syncytial Virus (RSV) vaccine market is entering a transformative era. With rising awareness of RSV's burden on public health especially among infants, the elderly, and immunocompromised individual’s healthcare systems are urgently embracing innovative immunization strategies. According to Transparency Market Research, the global RSV vaccine market, which was valued...
0 Reacties 0 aandelen 0 voorbeeld
Sponsor
Omaada - A global social and professionals networking platform https://www.omaada.com